Bone marrow dysfunction in chronic heart failure patients (Q43081654)

13 November 2017

title

Bone marrow dysfunction in chronic heart failure patients (English)

1 reference

13 November 2017

1 reference

chronic heart failure

1 reference

9

1 reference

13 November 2017

6

Pim van der Harst

0 references

Dirk J van Veldhuisen

8

object named as

Dirk J van Veldhuisen

1 reference

13 November 2017

2

Adriaan A Voors

1 reference

13 November 2017

B Daan Westenbrink

1

1 reference

13 November 2017

Rudolf A de Boer

3

1 reference

13 November 2017

Jan J Schuringa

4

1 reference

13 November 2017

Theo Klinkenberg

5

1 reference

13 November 2017

Pim van der Harst

6

1 reference

13 November 2017

Edo Vellenga

7

1 reference

13 November 2017

publication date

28 April 2010

1 reference

European Journal of Heart Failure

13 November 2017

published in

1 reference

13 November 2017

volume

12

1 reference

13 November 2017

issue

7

1 reference

13 November 2017

page(s)

676-684

1 reference

Erythropoietin in cardiovascular diseases.

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Anemia and mortality in heart failure patients a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Anemia and chronic heart failure implications and treatment options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Pathogenesis and treatment of anaemia of chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Telomere gap between granulocytes and lymphocytes is a determinant for hematopoetic progenitor cell impairment in patients with previous myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Telomere Length of Circulating Leukocytes Is Decreased in Patients With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

Anemia in chronic heart failure: etiology and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ061

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFQ061

1 reference

13 November 2017

1 reference